integrin alpha-4/beta-1 antagonists (Perrigo)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameintegrin alpha-4/beta-1 antagonists (Perrigo)
Drug Alias Nameintegrin alpha-4/beta-1 antagonists (Elan)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-4/beta-1 antagonists
TargetsIntegrin alpha-4/beta-1
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesElan Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPerrigo Company PlcElan Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A